Literature DB >> 9440098

Malignant hypertension and hypertensive emergencies.

C Kitiyakara1, N J Guzman.   

Abstract

Hypertensive emergencies and urgencies are important causes of morbidity and mortality. Malignant hypertension is a hypertensive urgency characterized by grade III/IV retinopathy and widespread endothelial damage. Control of BP is essential in the treatment of these disorders. The effects of hypertension on target organ function need to be balanced against the risks of excessive BP lowering. In hypertensive emergencies, BP should be lowered within minutes with parenteral agents to prevent critical end-organ damage. In hypertensive urgencies, BP can be lowered more slowly over several hours, often with oral agents, to avoid a detrimental fall in BP. The absolute indications for treatment and the optimal therapy depend on the underlying condition.

Entities:  

Mesh:

Year:  1998        PMID: 9440098     DOI: 10.1681/ASN.V91133

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

Review 1.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

2.  A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.

Authors:  Paul M McKie; Alessandro Cataliotti; Guido Boerrigter; Horng H Chen; S Jeson Sangaralingham; Fernando L Martin; Tomoko Ichiki; John C Burnett
Journal:  Hypertension       Date:  2010-10-25       Impact factor: 10.190

3.  Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension.

Authors:  Shantel A Vital; Satoshi Terao; Mutsumi Nagai; D Neil Granger
Journal:  Microcirculation       Date:  2010-11       Impact factor: 2.628

Review 4.  Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature.

Authors:  David Cherney; Sharon Straus
Journal:  J Gen Intern Med       Date:  2002-12       Impact factor: 5.128

Review 5.  [Hypertensive emergencies].

Authors:  A Link; K Walenta; M Böhm
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

Review 6.  M-atrial natriuretic peptide: a novel antihypertensive protein therapy.

Authors:  Paul M McKie; Tomoko Ichiki; John C Burnett
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

7.  An experimental model for hypertensive crises emergencies: Long-term high-fat diet followed by acute vasoconstriction stress on spontaneously hypertensive rats.

Authors:  Hong Liu; Wei-Wei Su; Chao-Feng Long; Wei-Jian Zhang; Pei-Bo Li; Zhong Wu; Yin-Yin Liao; Xuan Zeng; Tao-Bin Chen; Yu-Ying Zheng; Zeng-Hao Yan; Cong Bi; Hong-Liang Yao
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-14

8.  Hypertensive crisis in children and adolescents.

Authors:  Tomáš Seeman; Gilad Hamdani; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

Review 9.  Treatment of hypertensive urgencies and emergencies.

Authors:  C Venkata S Ram; Russell L Silverstein
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

10.  Prevalence, determinants, and clinical significance of cardiac troponin-I elevation in individuals admitted for a hypertensive emergency.

Authors:  Luis Afonso; Himabindu Bandaru; Ankit Rathod; Apurva Badheka; Mohammad Ali Kizilbash; Hammam Zmily; Gordon Jacobsen; Joseph Chattahi; Tamam Mohamad; Jayanth Koneru; John Flack; W Douglas Weaver
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-06-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.